SpineVision Inks $10M

SpineVision, a French medical device company that designs, develops and markets products for the surgical treatment of spine disorders, has raised $10 million in fresh capital. The round was led by healthcare investment specialist Omega Funds, a new investor in the company.

7 May 2013•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail